| Old Articles: <Older 20431-20440 Newer> |
|---|
 |
The Motley Fool
February 2, 2007
Rich Smith |
Foolish Forecast: Soothsaying Cisco The networking giant is set to report its fiscal second-quarter 2007 numbers. Investors, here is what you can expect to see.   |
The Motley Fool
February 2, 2007
Rich Duprey |
Dolby Keeps Playing: Fool by Numbers The audio company released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
February 2, 2007
Tim Beyers |
Delta Dodges US Airways Creditors choose to double down on the beleaguered carrier. Bad move. Do you really believe this is a business worth your investment? |
The Motley Fool
February 2, 2007
Steven Mallas |
Clorox Cleans Up on Wall Street Clorox comes clean with its second-quarter numbers. Investors, this is a good candidate for a dollar-cost-averaging strategy within the environment of a long-term portfolio. |
The Motley Fool
February 2, 2007
David Lee Smith |
Smell the Flowers Foods The debt-to-equity ratio is one number that makes this bakery company look good to investors, too. |
The Motley Fool
February 2, 2007
Alyce Lomax |
The Game's On at EA Investors gave Electronic Arts' third-quarter earnings report high scores. |
The Motley Fool
February 2, 2007 |
Electronic Arts Needs Speed: Fool by Numbers The video game developer released third-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
February 2, 2007
Rich Smith |
Peering at Spherion Investors, things are going well for Spherion, and in contrast with Manpower's dour report, it provides a pleasant "second opinion" on the economy's health. |
The Motley Fool
February 2, 2007
Anders Bylund |
Ericsson's Broken Promises Don't make promises you can't keep, especially if you're the CEO of a public company. Investors, the company didn't quite meet the lofty cash flow target set by CEO Carl-Henric Svanberg. |
The Motley Fool
February 2, 2007 |
Celgene Looks Stellar: Fool by Numbers The biopharmaceutical released fourth-quarter 2006 earnings. Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
| <Older 20431-20440 Newer> Return to current articles. |
